A silver-haired couple in their 60s laughing together over breakfast at a sunlit wooden kitchen table, vibrant and healthy
Longevity Medicine · Guide
HSA/FSA eligible

CBT-I Insomnia

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, non-medication treatment that targets the thoughts and behaviors keeping you awake.

Free
Sleep assessment
$149
At-home sleep apnea test
$2/day
CPAP therapy, from
HIPAA-Secure
FDA-Cleared Devices
Free and Fast Shipping
Certified Sleep Experts
No In-Person Visit Needed
Clear Pricing, No Hidden Fees
Secure Payments

Start here · Free

Not sure where your sleep stands? Start with two minutes.

Answer a few quick questions about how you sleep and how you feel during the day. You get a read on your sleep type and the step that fits you next, before you spend anything.

Free sleep assessment

2 min

No cost. No commitment.

  • Your sleep type, in plain words
  • Where your sleep is heading
  • The next step that fits you

Sleep Longevity

See how your sleep is aging you.

A blood panel and the wearable you already own, turned into one number: your SleepLongevityAge™. Then a clinical plan to bring it down.

  • 51 sleep-focused biomarkers, drawn twice a year
  • Your SleepLongevityAge™ tracked over time
  • Blood draw at home, or at a lab near you
  • Connect the wearable you already own

Core membership

$0.99/day

Billed annually · $365/year

Early-member rate. Standard price $500/year.

HSA and FSA eligible. Cash pay, no insurance needed.

A man wearing the WatchPAT ONE home sleep test on his wrist and finger

Suspect sleep apnea?

Test in your own bed. Answers in 48 hours.

One night with an FDA-cleared device. No wires, no sleep lab. A board-certified doctor reviews your results, with a prescription included if you need one.

$149$350Save 58%

  • Free shipping, next business day
  • HSA/FSA eligible
  • No insurance needed

Already diagnosed?

Treatment and support that stay with you.

Starting CPAP or already on it, Dumbo Health handles the equipment, the supplies, and the follow-up.

Starting CPAP

Start CPAP from $2 a day.

Have a prescription? Get your machine, setup, and supplies, plus a care team that checks your therapy data every night.

  • Machine, setup, and supplies included
  • One monthly price, no surprise bills
  • Cancel anytime, return the device, no fee

Already on CPAP

Get support that shows up.

Supplies shipped based on how much you actually use your machine, not a calendar. Plus licensed clinicians who spot problems early.

  • Data-triggered resupply
  • Clinical help before small issues become reasons to quit
  • Cancel anytime

The full guide

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured, non-medication treatment that targets the thoughts and behaviors keeping you awake. The American College of Physicians recommends CBT-I as the first-line treatment for chronic insomnia in adults, ahead of any sleeping pill or sleep medication. This guide is written for anyone struggling with persistent sleep problems, wearable users noticing poor sleep efficiency, and health-conscious adults who want to understand how insomnia connects to biological aging and long-term health. You will find a complete breakdown of every core CBT-I component, how each technique works, who benefits most, limitations to be aware of, and how sleep quality feeds into measurable longevity biomarkers. Whether you have been dealing with insomnia for weeks or years, this page gives you the clinical detail and practical steps to act on.

Quick Answer

Cognitive Behavioral Therapy for Insomnia (CBT-I) is a structured program, typically lasting 4 to 8 sessions, that uses sleep restriction, stimulus control, cognitive restructuring, sleep hygiene education, and relaxation techniques to treat chronic insomnia without medications. The American College of Physicians and the American Academy of Sleep Medicine both endorse CBT-I as the preferred first-line treatment over pharmacotherapy. Research published through the NIH shows CBT-I produces durable improvements in sleep efficiency and total sleep time that persist long after treatment ends. Dumbo Health's sleep longevity program tracks sleep-related biomarkers that quantify how chronic insomnia accelerates biological aging.

Key Takeaways

  • CBT-I is recommended as the first-line treatment for chronic insomnia by the American College of Physicians and the American Academy of Sleep Medicine, ahead of any sleep medication.
  • A typical CBT-I program runs 4 to 8 sessions and combines five core techniques: sleep restriction, stimulus control, cognitive restructuring, sleep hygiene, and relaxation training.
  • CBT-I produces long-term improvements in sleep efficiency that medications alone do not sustain after discontinuation, according to research indexed on PubMed.
  • Chronic insomnia is associated with elevated inflammatory markers such as hs-CRP and metabolic disruption, both of which Dumbo Health's 51-biomarker Core panel tracks twice a year for $0.99 a day.
  • Digital CBT-I programs such as Somryst (FDA-cleared), Sleepio, and CBT-I Coach expand access for people who cannot attend in-person behavioral sleep medicine sessions.
  • Untreated insomnia can coexist with or mask sleep apnea, which is why a comprehensive sleep assessment that includes objective testing matters before assuming insomnia is the only problem.

What CBT-I Is and Why It Works Better Than Sleeping Pills

CBT-I is a multi-component behavioral and cognitive treatment designed to break the cycle of chronic insomnia without relying on medications. It works by retraining the brain's association between the bed and sleep, compressing time in bed to build stronger homeostatic sleep drive, and dismantling the anxious thought patterns that fuel conditioned arousal.

Cognitive Behavioral Therapy for Insomnia is not a single technique. It is a structured protocol that combines five distinct interventions: sleep restriction therapy, stimulus control therapy, cognitive restructuring, sleep hygiene education, and relaxation techniques. Each component addresses a different layer of the insomnia problem, which is why CBT-I outperforms any single behavioral intervention used alone.

The reason CBT-I works better than a sleeping pill for most people comes down to durability. According to research cited by the National Institutes of Health, medication-based approaches often lose effectiveness once the drug is discontinued, and some carry risks of dependence. CBT-I, by contrast, teaches skills that remain effective because the patient's sleep system has been retrained rather than chemically overridden.

The American College of Physicians published a clinical practice guideline recommending CBT-I as the initial treatment for chronic insomnia disorder in adults. The American Academy of Sleep Medicine similarly positions CBT-I as the standard of care in behavioral sleep medicine. These are not soft endorsements. They reflect systematic reviews of randomized controlled trials showing CBT-I produces meaningful, lasting improvements in sleep onset latency, wake after sleep onset, and sleep efficiency.

DID YOU KNOW: A meta-analysis indexed on PubMed found that CBT-I improved sleep efficiency by an average of approximately 10 percentage points and reduced sleep onset latency by roughly 19 minutes, with effects maintained at follow-up assessments months after treatment ended.

Understanding why insomnia persists helps explain why CBT-I targets behavior and cognition rather than sedation. The three-factor model of insomnia, sometimes called the Spielman model, describes insomnia as developing through predisposing factors (such as genetic tendency toward hyperarousal), precipitating factors (such as a stressful life event), and perpetuating factors (such as spending excessive time in bed or clock-watching). CBT-I primarily targets the perpetuating factors, which is why it works even when the original trigger has long passed.

KEY TAKEAWAY: CBT-I is the evidence-based first-line treatment for chronic insomnia disorder, endorsed by both the American College of Physicians and the American Academy of Sleep Medicine, because it produces durable improvements that medications cannot sustain after discontinuation.

Understanding what CBT-I is sets the stage for examining each of its five core components in detail.

The Five Core Components of CBT-I

Each CBT-I component targets a specific mechanism that perpetuates insomnia, and the combination is what makes the treatment effective across different insomnia presentations.

Sleep Restriction Therapy

Sleep Restriction Therapy compresses your time in bed to match the amount of sleep you are actually getting, which builds homeostatic sleep drive and consolidates fragmented sleep into a solid block. If your sleep diary shows you are sleeping roughly 5.5 hours despite spending 8 hours in bed, your initial bedtime window would be set to approximately 5.5 to 6 hours.

This sounds counterintuitive, and the first few days often feel harder. But the mild sleep deprivation creates a powerful biological pressure to sleep, which retrains the brain to associate the bed with rapid sleep onset rather than frustration. As sleep efficiency improves above 85 percent, the bedtime window is gradually expanded in 15- to 30-minute increments.

Sleep Restriction Therapy is considered one of the most effective single components of CBT-I. The Sleep Foundation explains that restricting time in bed reduces the conditioned arousal that develops when a person lies awake for long periods night after night.

Sleep Restriction Therapy should be guided by a trained clinician, especially for people with bipolar disorder, seizure disorders, or occupations requiring sustained alertness, because the initial sleep deprivation phase can temporarily increase daytime sleepiness.

Stimulus Control Therapy

Stimulus Control Therapy rebuilds the learned association between your bedroom and sleep. Over time, people with chronic insomnia develop conditioned arousal in response to the bed and bedroom, meaning the environment that should trigger drowsiness instead triggers wakefulness and anxiety.

The rules of Stimulus Control Therapy are simple but strict:

  • Go to bed only when sleepy.
  • Use the bed only for sleep (and intimacy).
  • If you cannot fall asleep within roughly 15 to 20 minutes, get up and move to another room. Return only when sleepy.
  • Wake at the same time every morning regardless of how much you slept.
  • Avoid naps during the initial treatment phase.

These rules break the negative bedroom associations that perpetuate insomnia. The technique was developed by sleep researcher Richard Bootzin and remains one of the most consistently supported behavioral interventions in insomnia research.

Cognitive Restructuring

Cognitive restructuring is the cognitive therapy component of CBT-I. It identifies and challenges the unhelpful beliefs and catastrophic thoughts about sleep that increase sleep-interfering arousal.

Common cognitive distortions in insomnia include beliefs such as "I will not be able to function at all tomorrow if I do not sleep 8 hours" or "My insomnia is permanently damaging my body." While poor sleep does carry real health consequences, the catastrophizing itself creates a feedback loop: worry about not sleeping triggers hyperarousal, which makes sleep even harder, which confirms the worry.

Cognitive therapy in CBT-I teaches the patient to evaluate these thoughts against evidence, develop more balanced sleep-related beliefs, and reduce the performance anxiety that turns a bad night into a chronic pattern.

Sleep Hygiene Education

Sleep hygiene refers to the environmental and behavioral practices that support healthy sleep. On its own, sleep hygiene education is not sufficient to treat insomnia disorder, which is why it is one component of CBT-I rather than the entire treatment. But when combined with the other techniques, it eliminates common saboteurs.

Key sleep hygiene practices include:

  • Keeping the bedroom cool, dark, and quiet.
  • Avoiding caffeine for at least 6 hours before bed.
  • Limiting alcohol consumption, which fragments sleep architecture even when it speeds sleep onset.
  • Reducing screen exposure in the hour before bed to minimize bright light exposure that suppresses melatonin.
  • Avoiding large meals close to bedtime.
  • Maintaining a consistent sleep schedule, including weekends.

The CDC notes that adults generally need at least 7 hours of sleep per night, and environmental factors play a measurable role in whether that sleep is restorative or fragmented.

Relaxation Techniques

Relaxation training addresses the physiological hyperarousal that keeps the body in a state incompatible with sleep onset. Several evidence-based relaxation methods are used within CBT-I:

  • Progressive muscle relaxation involves systematically tensing and releasing muscle groups to reduce physical tension.
  • Diaphragmatic breathing slows the autonomic nervous system.
  • Mindfulness-based techniques, including mindfulness training and body scan meditation, reduce cognitive and somatic arousal.
  • Biofeedback provides real-time physiological data (such as muscle tension or heart rate) to help patients learn voluntary relaxation.

Relaxation strategies work best when practiced consistently, not just at bedtime. Building a relaxation practice during the day trains the nervous system to down-regulate more easily when sleep time arrives.

KEY TAKEAWAY: The five core CBT-I components work together to address every layer of chronic insomnia: sleep restriction builds sleep drive, stimulus control retrains bedroom associations, cognitive restructuring breaks anxious thought loops, sleep hygiene removes environmental saboteurs, and relaxation techniques reduce physiological arousal.

With the core techniques understood, the next step is examining how insomnia connects to biological aging and measurable health outcomes.

How Chronic Insomnia Accelerates Biological Aging

Chronic insomnia does not just make you tired. It shifts measurable biomarkers in directions associated with accelerated biological aging. Persistent sleep disruption elevates inflammatory markers, impairs metabolic regulation, and alters hormonal balance in ways that compound over months and years.

Research indexed on PubMed has linked chronic insomnia to elevated levels of hs-CRP (high-sensitivity C-reactive protein), a systemic inflammation marker that also independently predicts cardiovascular risk. The National Institute on Aging explains that biological age can diverge meaningfully from chronological age, and chronic sleep disruption is one of the modifiable factors that widens that gap.

Insomnia also affects metabolic health. Poor sleep efficiency is associated with impaired glucose regulation, increased insulin resistance, and shifts in appetite-regulating hormones such as leptin and ghrelin. These metabolic changes are detectable through blood biomarkers well before they produce clinical disease, which is why biomarker-based monitoring offers an early warning system that symptom tracking alone cannot provide.

Hormonal disruption is another pathway. Cortisol, the primary stress hormone, follows a circadian rhythm that peaks in the morning and falls at night. Chronic insomnia can flatten or dysregulate this curve, leading to elevated evening cortisol that perpetuates sleep-interfering arousal and contributes to a cycle that is difficult to break without intervention. DHEA-S, testosterone, and other hormonal markers also shift in response to sustained sleep loss, which is why Dumbo Health's Hormone and Vitality add-on pack includes testosterone variants, DHEA-S, and menopause-related markers alongside core sleep-longevity biomarkers.

Dumbo Health's proprietary SleepLongevityAge metric quantifies this relationship directly. The score is built from blood biomarkers, combined with optional data from wearable devices such as Oura, Whoop, or Garmin, and reviewed by board-certified physicians. For someone with chronic insomnia, tracking SleepLongevityAge over time reveals whether treatment is moving the needle on biological aging or merely improving subjective sleep perception.

The Dumbo Health Core membership tests 51 sleep-longevity biomarkers twice a year, including inflammation markers, metabolic panels, and hormonal indicators that chronic insomnia directly affects. At $0.99 a day for early members, billed annually at $365 a year, it provides the objective data layer that CBT-I outcomes need to be measured against biological aging rather than self-reported symptoms alone.

KEY TAKEAWAY: Chronic insomnia accelerates biological aging through measurable changes in inflammation, metabolic function, and hormonal regulation, all of which can be tracked through biomarker testing to determine whether treatment is producing real physiological improvement.

The biological impact of insomnia explains why treatment access matters. The next section covers how to actually access CBT-I.

How to Access CBT-I: In-Person, Digital, and Telehealth Options

CBT-I can be delivered through in-person sessions with a behavioral sleep medicine specialist, through digital CBT-I programs, or through telemedicine platforms, each with different tradeoffs in cost, convenience, and clinical oversight.

In-Person CBT-I

The gold standard for CBT-I delivery is working directly with a trained sleep clinician, typically a psychologist or behavioral sleep medicine specialist credentialed by the American Academy of Sleep Medicine. In-person CBT-I usually involves 4 to 8 weekly sessions lasting 30 to 60 minutes each.

The challenge is access. There are relatively few board-certified behavioral sleep medicine providers in the United States. Many sleep centers focus on diagnosing and treating sleep apnea rather than delivering cognitive behavioral treatment for insomnia. Patients in rural areas or those without sleep centers nearby often face long wait times or none at all.

In-person CBT-I can be delivered in group and individual treatment formats. Group treatment has shown comparable efficacy to individual therapy in several trials, and it can reduce cost and wait times at medical centers that offer it.

Digital CBT-I Programs

Digital CBT-I has expanded access significantly. These programs deliver the same core components through guided online modules, interactive sleep diaries, and automated session scheduling.

Three digital CBT-I programs have the strongest evidence base:

  • Somryst (now marketed as Pear-004) received FDA-approval as a prescription digital therapeutic for chronic insomnia. It delivers a 9-week CBT-I program through a mobile app.
  • Sleepio is a widely studied digital CBT-I program that uses an animated virtual therapist to guide users through 6 sessions of CBT-I content.
  • CBT-I Coach, developed by the VA (Department of Veterans Affairs), is a free app originally designed as a companion to clinician-delivered CBT-I but also used as a standalone tool. It includes sleep diary tracking, sleep education, and relaxation exercises.

Other digital CBTI interventions and sleep apps, including Goodnight Insomnia, provide additional options, though their evidence base varies. When evaluating any digital CBT program, look for programs that include all five core CBT-I components rather than offering sleep hygiene tips alone.

DID YOU KNOW: A systematic review published through the NIH found that digital CBT-I programs produced significant improvements in insomnia severity, sleep onset latency, and sleep efficiency, with effect sizes comparable to face-to-face delivery for many outcome measures.

Telehealth CBT-I and Telemedicine Access

Telemedicine has created a middle path between fully self-guided digital programs and in-person sessions. Several behavioral sleep medicine providers now deliver CBT-I through video consultations, which preserves the clinician relationship while removing geographic barriers.

For people whose insomnia coexists with other sleep disorders such as sleep apnea or restless legs syndrome, a telehealth-based approach with a health care provider who can evaluate and treat both conditions offers a significant advantage over standalone digital programs. Dumbo Health's telehealth clinical support, currently available in Florida and Texas for sleep apnea care, integrates sleep apnea diagnosis with the broader longevity membership so that comorbid sleep conditions are not treated in isolation.

Choosing the Right Access Path

The best access path depends on severity, comorbidities, and personal preference. Here is how the three approaches compare:

Clinical Oversight Level

  • In-Person CBT-I: Direct, session-by-session clinician guidance
  • Digital CBT-I (Somryst, Sleepio): Automated with optional clinician check-ins
  • Telehealth CBT-I: Direct clinician guidance via video

Typical Duration

  • In-Person CBT-I: 4 to 8 weekly sessions
  • Digital CBT-I (Somryst, Sleepio): 6 to 9 weeks of self-paced modules
  • Telehealth CBT-I: 4 to 8 weekly sessions via video

Cost Range

  • In-Person CBT-I: Varies widely; often $150 to $300 per session without insurance
  • Digital CBT-I (Somryst, Sleepio): $0 (CBT-I Coach) to prescription cost (Somryst)
  • Telehealth CBT-I: Typically lower than in-person; varies by provider

Best For

  • In-Person CBT-I: Complex insomnia with comorbid conditions requiring hands-on assessment
  • Digital CBT-I (Somryst, Sleepio): Uncomplicated chronic insomnia in motivated self-starters
  • Telehealth CBT-I: People who want clinician guidance without geographic or scheduling constraints

For anyone pursuing CBT-I, pairing treatment with objective biomarker tracking through a program like the Dumbo Health sleep longevity membership adds a data layer that neither self-reported sleep diaries nor wearable metrics alone can provide.

KEY TAKEAWAY: CBT-I is available through in-person specialists, FDA-cleared digital programs, and telemedicine, with digital options expanding access for people who cannot see a behavioral sleep medicine provider in their area.

Knowing how to access CBT-I is one thing. Knowing how to actually go through the process, step by step, is another.

How to Start and Complete a CBT-I Program

Starting CBT-I involves a structured process from initial assessment through graduated treatment to maintenance. Here is how to move from recognizing a sleep problem to completing a full course of treatment.

Step-by-Step Process for Completing CBT-I

  1. Complete a sleep assessment. Track your sleep patterns using a sleep diary for at least 1 to 2 weeks before starting treatment. Record bedtime, wake time, estimated sleep onset latency, nighttime awakenings, and how rested you feel. Take the free sleep longevity assessment at Dumbo Health to evaluate how your sleep patterns may be affecting biological aging.
  2. Rule out comorbid sleep disorders. Before assuming insomnia is your only problem, screen for sleep apnea, restless legs syndrome, and circadian rhythm disorders. Untreated sleep apnea can mimic or worsen insomnia, and CBT-I alone will not resolve breathing-related sleep disturbances. Dumbo Health's at-home sleep apnea test costs $149, is FDA-cleared, and delivers physician diagnosis typically within 48 hours.
  3. Choose your CBT-I delivery format. Decide between in-person sessions with a behavioral sleep medicine specialist, a digital CBT-I program (such as Somryst, Sleepio, or CBT-I Coach), or telehealth sessions based on the severity of your insomnia and your access to providers in your area.
  4. Establish your baseline sleep efficiency and bedtime window. Your clinician or digital program will calculate your current sleep efficiency (time asleep divided by time in bed, multiplied by 100). This determines your initial bedtime window for Sleep Restriction Therapy.
  5. Begin the active treatment phase. Follow the assigned sleep restriction schedule, implement stimulus control rules, practice relaxation techniques daily, and work through cognitive restructuring exercises during weekly sessions. Adherence management during this phase matters more than perfection. Expect some daytime sleepiness in the first 1 to 2 weeks.
  6. Expand your bedtime window as sleep efficiency improves. When your sleep efficiency consistently exceeds 85 percent for a week, your bedtime window is extended by 15 to 30 minutes. This process continues until you reach a sustainable sleep duration.
  7. Transition to maintenance and relapse prevention. After completing the active treatment phase (typically 4 to 8 sessions), develop a relapse prevention plan. This includes identifying early warning signs, maintaining consistent wake times, and knowing when to re-implement sleep restriction if insomnia begins to return.

Completing a full CBT-I program typically takes 6 to 12 weeks. The skills learned during treatment are designed to be self-sustaining, which is what separates CBT-I from pharmacotherapy that requires ongoing use.

KEY TAKEAWAY: A complete CBT-I program follows a structured sequence from sleep assessment and comorbidity screening through active treatment with sleep restriction and stimulus control to maintenance and relapse prevention, typically over 6 to 12 weeks.

Once you understand the treatment process, it helps to see how CBT-I plays out for different types of people.

Who Benefits Most from CBT-I: Real-World Scenarios

CBT-I is effective across a wide range of insomnia presentations, but the way it helps varies depending on the individual's age, comorbidities, and what is driving their sleep problem.

Common Scenarios

A 38-year-old software engineer who lies awake for 60 to 90 minutes most nights, scrolling through worst-case scenarios about the next day. Her sleep diary shows a sleep efficiency of 68 percent. She has tried melatonin supplements and alcohol before bed, neither of which has helped and the alcohol has actually worsened her sleep architecture by fragmenting her sleep cycles. For her, the cognitive restructuring and stimulus control components of CBT-I address the conditioned arousal and catastrophic thinking that are the primary perpetuating factors. Within 4 weeks of treatment, her sleep efficiency improves to 82 percent, and by week 6, she is consistently above 85 percent without any sleep medication.

A 52-year-old executive with a family history of cardiovascular disease who uses an Oura ring and has noticed declining deep sleep percentages and increasing resting heart rate over the past year. His health care provider has not identified a specific sleep disorder, but he reports difficulty maintaining sleep, waking at 3 a.m. and being unable to return to sleep. CBT-I targets his sleep-related behaviors, particularly the habit of lying in bed awake and the anxiety about health consequences that fuels his middle-of-the-night wakefulness. Because of his cardiovascular risk profile, he also enrolls in Dumbo Health's Core membership to track inflammatory and metabolic biomarkers twice a year alongside his wearable data. His SleepLongevityAge score gives him an objective benchmark that his wearable alone cannot provide.

A 67-year-old retired teacher with chronic insomnia who has been taking a prescription sleeping pill for 4 years and wants to discontinue it. Her internal medicine physician referred her to a behavioral sleep medicine specialist. The CBT-I program is combined with a gradual medication taper supervised by her prescriber. Sleep Restriction Therapy rebuilds her homeostatic sleep drive, which had been suppressed by years of hypnotic use. The cognitive therapy component addresses her fear that she "cannot sleep without the pill." After 8 sessions, she is sleeping without medication for the first time in years, with a sleep efficiency above 87 percent.

A 29-year-old night-shift nurse whose insomnia is partly driven by circadian rhythm disruption. Standard CBT-I helps, but her clinician also incorporates biological clock considerations, including timed bright light exposure during her shift and strategic light avoidance before her daytime sleep window. Her case illustrates that CBT-I sometimes needs to be adapted for shift workers, and that insomnia models like the three-factor model must account for circadian misalignment alongside behavioral and cognitive factors.

KEY TAKEAWAY: CBT-I is effective across diverse insomnia presentations, from anxiety-driven sleep onset insomnia to medication-dependent chronic insomnia to shift-work-related circadian disruption, but the emphasis on specific components varies by individual.

These examples show what success looks like. The next section addresses the situations where CBT-I may not be the right fit or may need to be modified.

Limitations of CBT-I and When It May Not Be the Right Choice

CBT-I is highly effective, but it is not appropriate for everyone, and it does not work in every clinical situation without modification.

The first limitation is adherence. Sleep Restriction Therapy requires significant short-term discomfort: reducing time in bed, tolerating increased daytime sleepiness, and resisting the urge to nap. People who cannot commit to the protocol, whether due to work demands, caregiving responsibilities, or personal preference, may not see full benefit. Adherence management is built into clinician-delivered programs but is harder to maintain with self-guided digital CBT-I programs.

The second limitation involves comorbid sleep disorders. CBT-I does not treat sleep apnea. If obstructive sleep apnea is present alongside insomnia, a condition sometimes called comorbid insomnia and sleep apnea (COMISA), CBT-I alone will not resolve the breathing-related sleep disturbance. A sleep study or at-home sleep test is necessary to rule out sleep apnea before or during CBT-I treatment. Dumbo Health's $149 at-home sleep apnea test provides an FDA-cleared diagnostic pathway that can run in parallel with behavioral treatment, ensuring that apnea-related sleep disturbances are not missed.

The third limitation concerns certain psychiatric and medical conditions. People with untreated bipolar disorder, active substance use disorders, or seizure disorders may need modified protocols or may not be candidates for standard Sleep Restriction Therapy due to the risks of sleep deprivation. In these cases, a health care provider with expertise in both sleep medicine and the comorbid condition should manage treatment.

The fourth consideration is that CBT-I requires active participation. Unlike taking a sleeping pill, CBT-I demands that the patient complete homework, maintain a sleep diary, restructure thoughts, and follow strict behavioral rules. For people in acute crisis or experiencing severe depression, the activation energy required for CBT-I may be too high until the acute phase is stabilized.

A fifth limitation involves cultural considerations. CBT-I was developed and validated primarily in Western clinical settings. Sleep-related behaviors, bedroom arrangements (such as co-sleeping with children or a bed partner), and beliefs about sleep vary across cultures. Effective CBT-I delivery sometimes requires adapting the standard protocol to respect these differences, which is more feasible in clinician-delivered formats than in rigid digital programs.

If you suspect you have both insomnia and sleep apnea, do not assume CBT-I alone will resolve your sleep problems. Objective testing for sleep apnea is essential, and Dumbo Health offers an all-inclusive at-home sleep apnea test with physician diagnosis typically within 48 hours.

Despite these limitations, for the majority of adults with chronic insomnia disorder, CBT-I remains the most effective and durable treatment available. Where CBT-I falls short, it is usually because the treatment was delivered incompletely, adherence was insufficient, or a comorbid condition was not adequately addressed rather than because the approach itself is flawed.

KEY TAKEAWAY: CBT-I has real limitations, including adherence difficulty, inability to treat sleep apnea, and the need for adaptation in certain medical and cultural contexts, but most failures stem from incomplete treatment or undiagnosed comorbidities rather than from the method itself.

Knowing the limitations helps set realistic expectations. The next section separates persistent myths from clinical facts.

Common Myths About CBT-I and Insomnia Debunked

MYTH: If you just practice good sleep hygiene, you do not need CBT-I.

FACT: Sleep hygiene education alone is not an effective standalone treatment for chronic insomnia disorder. The American Academy of Sleep Medicine clinical practice guidelines are clear that sleep hygiene by itself has insufficient evidence to recommend as a single therapy for insomnia. Sleep hygiene practices such as keeping the bedroom cool and avoiding caffeine are helpful supporting habits, but they do not address the conditioned arousal, dysfunctional beliefs, and disrupted sleep drive that perpetuate chronic insomnia. That is why sleep hygiene is one of five components within CBT-I, not the whole treatment.

MYTH: CBT-I is just about thinking positive thoughts before bed.

FACT: Cognitive restructuring is one component of CBT-I, but it is not about positive thinking. It is a structured process for identifying specific distorted beliefs about sleep, evaluating them against evidence, and developing more accurate sleep-related cognitions. The behavioral components, particularly sleep restriction and stimulus control, often drive the largest initial improvements. CBT-I is fundamentally a behavioral treatment with a cognitive component, not a positive-thinking exercise.

MYTH: Sleeping pills are safer and faster than CBT-I, so there is no reason to try behavioral treatment first.

FACT: While sleep medications can reduce sleep onset latency on any given night, they do not produce lasting improvement in sleep architecture or sleep efficiency after discontinuation. The American College of Physicians specifically recommends CBT-I before pharmacotherapy because the benefits persist after treatment ends. According to the NIH, long-term use of certain hypnotic medications carries risks including dependence, cognitive impairment, and increased fall risk in older adults. CBT-I has no comparable side effect profile.

MYTH: If CBT-I does not work in the first week, it is not going to work.

FACT: The first 1 to 2 weeks of CBT-I, especially during the sleep restriction phase, often feel worse before they feel better. Increased daytime sleepiness and a temporary reduction in total sleep time are expected and are actually part of the mechanism. Sleep efficiency typically begins improving meaningfully by weeks 3 to 4, with full benefit consolidating over 6 to 8 weeks. Abandoning CBT-I in the first week is like stopping an antibiotic after one dose because the infection is still present.

MYTH: Wearables and sleep apps can replace CBT-I.

FACT: Wearable devices such as Oura, Whoop, and Garmin provide useful data on sleep patterns, heart rate variability, and sleep stages, but they do not deliver therapeutic interventions. Nearables and sleep apps can support CBT-I by providing objective sleep tracking, but they are not substitutes for the structured behavioral and cognitive interventions that make CBT-I effective. The most powerful combination is using wearable data alongside clinical biomarker testing, which is exactly what Dumbo Health's sleep longevity program enables by integrating wearable data with 51 blood biomarkers.

KEY TAKEAWAY: The most common myths about CBT-I reflect misunderstandings about how insomnia works: sleep hygiene alone is not enough, the treatment takes weeks rather than days, and no pill or wearable replaces the structured behavioral retraining that CBT-I provides.

With myths cleared, the next question is what to check before committing to a CBT-I program and a broader sleep health strategy.

What to Evaluate Before Starting CBT-I and Sleep Longevity Testing

Before beginning CBT-I or enrolling in a biomarker-based sleep longevity program, there are specific factors to verify so you get the most out of both.

Pre-CBT-I and Sleep Longevity Checklist

  • Maintain a sleep diary for at least 7 to 14 days, recording bedtime, wake time, estimated time to fall asleep, nighttime awakenings, naps, and subjective sleep quality.
  • Screen for sleep apnea, particularly if you snore, have observed breathing pauses, or have a BMI above 30. An at-home sleep apnea test through Dumbo Health costs $149 and delivers results typically within 48 hours.
  • List all current medications, including over-the-counter sleep aids, supplements, and any foods and substances (caffeine, alcohol, stimulants) that may be affecting your sleep.
  • Confirm whether your insomnia is primarily sleep-onset difficulty, sleep-maintenance difficulty, or early morning awakening, as this affects which CBT-I components are emphasized.
  • Discuss your insomnia with your health care provider to rule out medical conditions such as restless legs syndrome, thyroid dysfunction, or uncontrolled pain that may be contributing.
  • Take the free sleep longevity assessment at Dumbo Health to understand how your sleep quality may be influencing your biological age.
  • Decide on your CBT-I delivery format: in-person with a behavioral sleep medicine specialist, a digital program (Somryst, Sleepio, CBT-I Coach), or telehealth sessions.
  • Identify whether you have a bed partner whose sleep may be affected by your treatment protocol, particularly during the sleep restriction phase, and plan accordingly.
  • Review your sleep environment for factors that contradict stimulus control principles, such as using the bedroom for work, watching television in bed, or inconsistent bedroom temperature.
  • Consider baseline biomarker testing to establish your pre-treatment inflammatory, metabolic, and hormonal levels so you can track objective improvement alongside subjective sleep gains.

TIP: Starting CBT-I while simultaneously establishing baseline biomarkers through Dumbo Health's Core plan gives you an objective before-and-after comparison that goes beyond how you feel and into how your body is actually responding at a cellular level.

KEY TAKEAWAY: Thorough preparation before starting CBT-I, including sleep diary tracking, comorbidity screening, medication review, and baseline biomarker testing, maximizes the likelihood of durable treatment success.

Understanding preparation leads naturally to how to measure whether CBT-I is actually working.

How to Measure CBT-I Success: Sleep Metrics and Biomarkers

CBT-I success is traditionally measured through patient-reported sleep outcomes such as sleep onset latency, wake after sleep onset, sleep efficiency, and total sleep time. These metrics are typically tracked through a sleep diary and sometimes supplemented by actigraphy.

Sleep efficiency is the primary metric. It is calculated by dividing total sleep time by total time in bed, then multiplying by 100. A sleep efficiency above 85 percent is generally considered a successful treatment outcome. According to the Sleep Foundation, healthy sleep efficiency typically falls between 85 and 95 percent.

Patient-reported sleep outcomes are essential but inherently subjective. People with insomnia frequently misperceive how long they take to fall asleep and how long they are awake during the night. This is one reason wearable devices and nearables have become popular adjuncts: they provide objective sleep data that can be compared against diary entries. However, consumer wearables measure sleep stages with variable accuracy and should not be treated as clinical-grade sleep study equipment.

The limitation of relying solely on sleep metrics is that they tell you whether you are sleeping better but not whether your body is aging differently as a result. This is where biomarker testing fills a critical gap.

Chronic insomnia elevates markers such as hs-CRP, shifts cortisol rhythms, impairs glucose regulation, and disrupts hormonal balance. If CBT-I is working at a biological level, these markers should move in favorable directions over time. Dumbo Health's Core membership tracks 51 sleep-longevity biomarkers twice a year, providing the objective data needed to assess whether improved sleep is translating into slowed biological aging. The SleepLongevityAge score synthesizes these biomarker results, combined with optional wearable data, into a single metric that tracks your trajectory.

For people who want even deeper insight, the Concierge membership tests 103 biomarkers twice a year, includes a dedicated sleep physician with 24/7 access, a personal sleep coach, and all add-on specialty packs. At $300 a month for early members, billed annually at $3,600 a year, the Concierge plan provides the most comprehensive monitoring available for people who are serious about understanding how their sleep is affecting their biological age.

The Dumbo Health Circadian and Stress add-on pack ($269) specifically tests morning cortisol plus a 4-point salivary cortisol curve, which directly measures one of the hormonal pathways most disrupted by chronic insomnia.

KEY TAKEAWAY: CBT-I success should be measured not only by improved sleep efficiency and reduced sleep onset latency but also by objective biomarker changes that indicate whether better sleep is producing measurable reductions in biological aging.

Measuring success with both behavioral metrics and biomarkers gives a complete picture. The next section addresses medications and how they fit alongside CBT-I.

Medications, Pharmacotherapy, and the Role of Sleep Medication Alongside CBT-I

CBT-I is recommended before sleep medication for chronic insomnia, but pharmacotherapy still has a role in specific clinical situations.

The American College of Physicians clinical practice guideline recommends that clinicians and patients discuss CBT-I as the initial treatment. If CBT-I alone is insufficient, the guideline suggests a shared decision about adding short-term pharmacotherapy. The emphasis on "shared decision" is important: medication may be appropriate for acute symptom relief during the early weeks of CBT-I when sleep restriction can temporarily worsen sleep quality, or for patients who cannot access CBT-I.

Common medications used for insomnia include benzodiazepine receptor agonists (such as zolpidem), melatonin receptor agonists (such as ramelteon), dual orexin receptor antagonists (such as suvorexant and lemborexant), and low-dose doxepin. Each has a different mechanism, side effect profile, and duration of action.

The critical distinction is that medications manage symptoms while CBT-I addresses causes. Pharmacotherapy does not retrain the sleep system, does not reduce conditioned arousal, and does not restructure dysfunctional beliefs about sleep. When medication is discontinued, the insomnia frequently returns because the perpetuating factors remain untreated.

Alcohol deserves specific mention. Many people self-medicate insomnia with alcohol, viewing it as a sedative. While alcohol speeds sleep onset, it severely disrupts sleep architecture in the second half of the night, reduces REM sleep, increases awakenings, and worsens sleep quality overall. The NIH notes that alcohol use before bed is associated with poorer sleep outcomes, making it counterproductive for anyone trying to improve sleep. CBT-I programs explicitly address alcohol and other stimulants as part of sleep hygiene education.

For people who have been on long-term sleep medication and want to transition to CBT-I, a gradual medication taper supervised by a health care provider is the safest approach. Abrupt discontinuation of hypnotic medications can cause rebound insomnia, which is often more severe than the original insomnia and can undermine confidence in the treatment transition.

KEY TAKEAWAY: Medications can provide short-term relief and may complement CBT-I during the initial treatment phase, but they do not address the underlying causes of chronic insomnia, and alcohol, though commonly used as a sleep aid, worsens sleep architecture and should be avoided.

Understanding how medications fit into the picture rounds out the clinical framework. The final step is pulling everything together.

Building a Long-Term Sleep Longevity Strategy After CBT-I

CBT-I is a treatment with a defined beginning and end, but the sleep habits and monitoring practices you build around it should be lifelong.

Relapse prevention is a formal component of CBT-I. It involves identifying early warning signs that insomnia is returning, such as spending increasing time in bed without sleeping, reverting to anxiety-driven thoughts about sleep, or reintroducing bedroom associations that conflict with stimulus control principles. Having a written relapse prevention plan that specifies when to re-implement sleep restriction and which cognitive exercises to use prevents a few bad nights from snowballing back into chronic insomnia.

Beyond behavioral maintenance, the biological dimension of sleep health requires ongoing monitoring. Sleep quality shifts with age, hormonal changes, medication changes, weight changes, and life stressors. A sleep assessment done once tells you where you are at a single point in time. Longitudinal biomarker tracking tells you where you are heading.

Dumbo Health's sleep longevity program is built around this principle. The Core membership ($0.99 a day for early members, billed annually at $365 a year, HSA and FSA eligible) provides 51 sleep-longevity biomarkers tested twice a year, SleepLongevityAge tracking over time, a personalized fix plan with physician support when needed, and optional wearable data integration. Blood draws are available through the Quest Diagnostics network, with more than 2,000 locations nationwide and roughly 9 in 10 people living within 20 minutes of a location. In-home mobile phlebotomist draws are available in select states.

For people who want the most comprehensive monitoring, the Concierge membership ($300 a month for early members, billed annually at $3,600 a year) includes 103 biomarkers tested twice a year, a dedicated sleep physician with 24/7 access, a personal sleep coach, and all add-on specialty packs. No insurance is required, no prior authorizations are needed, and there are no surprise bills.

Early-member pricing locks for life for the first 500 members, which means the rate you lock in today does not increase even as standard pricing rises.

The combination of CBT-I skills, consistent sleep hygiene practices, wearable tracking, and objective biomarker testing creates a comprehensive sleep longevity strategy. Sleep is not a standalone clinical issue. It is a modifiable input to biological aging, and treating it that way, with data and structure, produces compounding benefits over years and decades.

Cognitive Behavioral Therapy for Insomnia provides the behavioral foundation. Biomarker-driven monitoring ensures that foundation is translating into measurable physiological improvement. Together, they represent the most complete approach available to anyone serious about sleep longevity.

KEY TAKEAWAY: A long-term sleep longevity strategy combines the behavioral skills learned through CBT-I with ongoing biomarker testing to ensure improved sleep is producing measurable reductions in biological aging, not just better nights.

Conclusion

CBT-I remains the most effective and durable treatment for chronic insomnia, endorsed by every major sleep medicine organization as the first-line intervention ahead of any medication. Its five core components address the behavioral, cognitive, and physiological mechanisms that keep insomnia going, and the skills it teaches last long after treatment ends. But resolving insomnia is not the finish line. Sleep is a driver of biological aging, and knowing whether better sleep is translating into better biomarker trajectories requires objective measurement over time. Dumbo Health's sleep longevity assessment is a free starting point to understand how your sleep may be affecting your biological age, with Core membership biomarker testing available at $0.99 a day, HSA and FSA eligible, and no insurance required.

Frequently Asked Questions About CBT-I Insomnia

What is CBT-I?

CBT-I, or Cognitive Behavioral Therapy for Insomnia, is a structured, evidence-based treatment designed to address the thoughts, behaviors, and patterns that maintain chronic insomnia. Unlike sleeping pills, CBT-I targets the root causes of insomnia disorder rather than temporarily suppressing symptoms. Core components include sleep restriction therapy, stimulus control therapy, cognitive restructuring, sleep hygiene education, and relaxation techniques. The American Academy of Sleep Medicine and the American College of Physicians both recommend CBT-I as a first-line treatment for chronic insomnia disorder in adults.

How does CBT-I work?

CBT-I works by identifying and changing sleep-interfering behaviors and thought patterns that perpetuate insomnia. Sleep restriction therapy consolidates sleep by temporarily limiting time in bed to match actual sleep time, strengthening the homeostatic sleep drive. Stimulus control therapy rebuilds the association between the bedroom and sleep by discouraging wakefulness in bed. Cognitive restructuring challenges unhelpful beliefs about sleep. Relaxation training, including progressive muscle relaxation and mindfulness, reduces conditioned arousal. Together, these behavioral interventions reset the sleep-wake cycle and improve sleep efficiency over time.

Is CBT-I effective for treating chronic insomnia?

Yes. CBT-I is consistently shown to be highly effective for chronic insomnia disorder. According to the American Academy of Sleep Medicine, CBT-I is the recommended first-line treatment for chronic insomnia in adults. Research published in the Annals of Internal Medicine and reviewed by the American College of Physicians found that CBT-I produces meaningful, durable improvements in sleep quality, sleep onset, and nighttime waking. Importantly, improvements from CBT-I tend to be maintained long after treatment ends, which is an advantage over sleep medication alone.

How does CBT-I compare to sleeping pills?

CBT-I and sleeping pills both reduce insomnia symptoms, but they work differently and produce different long-term outcomes. Sleeping pills, including prescription sleep medication and over-the-counter aids, provide short-term relief but do not address the underlying behavioral and cognitive patterns driving insomnia disorder. CBT-I changes those patterns directly. Research consistently shows that CBT-I produces improvements that last beyond the treatment period, whereas insomnia often returns when sleep medication is stopped. The American College of Physicians recommends CBT-I as the first treatment to try before pharmacotherapy for chronic insomnia.

How long does CBT-I take to work?

Most people begin noticing improvements in sleep quality within two to four weeks of starting CBT-I, though the full course typically spans four to eight sessions over several weeks. Sleep restriction therapy can initially feel difficult, as time in bed is temporarily reduced to build homeostatic sleep drive before being gradually extended. Many people experience meaningful improvement in sleep efficiency and sleep patterns by the midpoint of treatment. Individual results vary depending on the severity of the insomnia disorder, adherence to the program, and any underlying health conditions.

Does CBT-I work without medication?

Yes. CBT-I is designed to work independently of sleep medication and is recommended as the first-line treatment precisely because it addresses insomnia without pharmacotherapy. Studies consistently show that CBT-I produces significant improvements in sleep onset, sleep duration, and nighttime waking without medication. Some people complete CBT-I while also tapering off existing sleep medication under clinician guidance, but CBT-I itself does not require any medication. A healthcare professional can advise whether combining CBT-I with medication is appropriate for an individual's situation.

What happens during a CBT-I session?

During a typical CBT-I session, a trained sleep clinician or behavioral sleep medicine specialist works with the patient to review sleep diary data, assess sleep patterns, and apply one or more CBT-I components. Early sessions focus on sleep education, stimulus control therapy, and beginning sleep restriction therapy. Later sessions introduce cognitive restructuring to address unhelpful beliefs about sleep, and relaxation strategies such as progressive muscle relaxation or mindfulness training. Relapse prevention is usually covered toward the end of treatment to help maintain sleep quality gains over time.

What is a sleep diary and why is it used in CBT-I?

A sleep diary is a daily record of sleep and wake times, time spent in bed, nighttime waking, nap habits, and factors such as alcohol or stimulant use that may affect sleep. In CBT-I, the sleep diary is a core clinical tool. It allows a sleep clinician to calculate sleep efficiency, set an accurate bedtime window for sleep restriction therapy, and track progress across sessions. Keeping a consistent sleep diary also helps patients become more aware of sleep-related behaviors and the relationship between daytime habits and nighttime sleep quality.

What are the potential benefits and risks of CBT-I?

The benefits of CBT-I include improved sleep quality, reduced time to fall asleep, fewer nighttime awakenings, and better daytime functioning, all without medication dependency. Improvements are generally sustained long after treatment ends. The main challenge, rather than a safety risk, is that sleep restriction therapy temporarily reduces time in bed, which can cause short-term tiredness and is not appropriate for everyone. People with certain conditions, including untreated bipolar disorder, seizure disorders, or severe sleep apnea, should discuss CBT-I suitability with a healthcare professional before starting. CBT-I does not carry the dependency or side-effect risks associated with sleep medication.

Who provides CBT-I?

CBT-I is delivered by trained healthcare professionals, including psychologists, sleep physicians, behavioral sleep medicine specialists, and licensed therapists with specific CBT-I training. It is available at sleep centers, medical centers, and mental health clinics. Telemedicine has made CBT-I significantly more accessible. A Harvard Health commentary by Suzanne Bertisch noted that CBT-I delivered via telemedicine shows comparable outcomes to in-person treatment for many patients. Digital CBT-I programs such as Sleepio and Somryst, which has received FDA authorization, offer structured self-guided programs that can be completed at home.

Can I do CBT-I at home or online?

Yes. Digital CBT-I programs and telehealth delivery have made it possible to complete a structured CBT-I program from home. FDA-authorized digital programs such as Somryst and app-based tools such as Sleepio and CBT-I Coach deliver core components including sleep restriction, stimulus control, and cognitive restructuring without requiring in-person visits. Research reviewed in Faculty Reviews confirms that digital CBT-I interventions produce meaningful improvements in patient-reported sleep outcomes. For people with complex insomnia or underlying sleep disorders such as sleep apnea or restless legs syndrome, evaluation by a sleep clinician is advisable alongside or before digital CBT-I programs.

Who can benefit from CBT-I?

CBT-I is appropriate for most adults with chronic insomnia disorder, defined as difficulty falling asleep, staying asleep, or waking too early at least three nights per week for three or more months. It is particularly well-suited for people who prefer to avoid or reduce sleep medication, those who have not responded fully to pharmacotherapy, and people with insomnia linked to stress, anxiety, or irregular sleep-wake patterns. Internal medicine physicians, primary care providers, and sleep specialists may recommend CBT-I as a starting point. Some populations, including those with untreated sleep apnea, should be assessed for underlying sleep disorders first.

Is CBT-I effective for insomnia related to stress, anxiety, or other health conditions?

CBT-I is effective for insomnia disorder whether or not it is linked to stress, anxiety, or other health conditions. Chronic insomnia often involves conditioned arousal, where the bedroom and bedtime become associated with wakefulness and worry rather than sleep. CBT-I directly addresses this through stimulus control therapy and cognitive restructuring. People with comorbid anxiety, depression, or chronic pain can benefit from CBT-I, though a healthcare provider may recommend addressing underlying conditions in parallel. CBT-I is not a substitute for treatment of a separate underlying health condition.

Does CBT-I address biological clock and circadian rhythm issues?

CBT-I incorporates biological clock considerations, particularly when sleep timing is irregular or shifted. Stimulus control therapy and sleep restriction therapy work in part by stabilising circadian rhythms through a consistent sleep schedule and wake time. Some CBT-I programs also include guidance on bright light exposure to support the biological clock. However, CBT-I is primarily a behavioral treatment for insomnia disorder rather than a dedicated circadian rhythm intervention. People with significant circadian rhythm disruption, such as shift workers or those with delayed sleep phase disorder, may benefit from additional specialist evaluation.

What is sleep restriction therapy and how does it fit into CBT-I?

Sleep restriction therapy is one of the most active components of CBT-I. It works by temporarily limiting time in bed to match the patient's actual sleep time, which builds homeostatic sleep drive and reduces nighttime waking. A clinician uses sleep diary data to set an initial bedtime window, which is gradually extended as sleep efficiency improves. Research published in Sleep by Perlis, Morin, Ivers and colleagues found that total sleep time does change appreciably during and after CBT-I as the bedtime window is adjusted. Sleep restriction therapy is not appropriate for everyone and should be supervised by a qualified clinician.

What is stimulus control therapy?

Stimulus control therapy is a behavioral intervention within CBT-I that strengthens the brain's association between the bedroom and sleep. It involves following specific guidelines such as only going to bed when sleepy, getting out of bed if unable to sleep, avoiding work, screens, or wakeful activities in the bedroom, and maintaining a consistent wake time. Over time, these practices reduce conditioned arousal and rebuild the bedroom as a reliable cue for sleep. Stimulus control therapy is consistently identified as one of the most effective single components of CBT-I for chronic insomnia disorder.

What relaxation techniques are used in CBT-I?

CBT-I incorporates several relaxation techniques to reduce the physiological and mental arousal that interferes with sleep onset. Progressive muscle relaxation involves systematically tensing and releasing muscle groups to reduce physical tension. Mindfulness training encourages non-judgmental awareness of thoughts and sensations without trying to force sleep. Diaphragmatic breathing and relaxation training are also commonly included. These relaxation methods do not work by forcing sleep but by reducing the sleep-interfering arousal that keeps people awake. Biofeedback is sometimes used in specialist settings to help patients learn to control physiological responses linked to insomnia.

How does sleep hygiene fit into CBT-I?

Sleep hygiene refers to a set of behavioral practices that support consistent, restorative sleep. In CBT-I, sleep hygiene education covers areas such as maintaining a regular sleep schedule, limiting alcohol, caffeine, and stimulants close to bedtime, managing the sleep environment, reducing naps, and minimising bright light exposure and screen use before bed. Sleep hygiene alone is not sufficient to resolve chronic insomnia disorder, but it supports the other CBT-I components. The Sleep Foundation notes that sleep hygiene practices are most effective when combined with behavioral interventions such as stimulus control and sleep restriction therapy.

Does CBT-I work if I have sleep apnea?

CBT-I can be appropriate for people with sleep apnea, particularly those who also have comorbid chronic insomnia disorder, but the underlying sleep apnea should be evaluated and managed first or in parallel. Untreated obstructive sleep apnea causes repeated breathing interruptions during sleep that disrupt sleep architecture in ways CBT-I alone cannot address. A healthcare provider or sleep physician can assess whether sleep apnea is contributing to insomnia symptoms. If sleep apnea is suspected, an at-home sleep apnea test may be a useful first step. Dumbo.health offers an at-home sleep apnea test for $149 with transparent, cash-pay pricing and no insurance required.

What is the success rate of CBT-I?

CBT-I is among the most evidence-supported treatments in behavioral sleep medicine. Clinical trials consistently show that around 70 to 80 percent of people with chronic insomnia disorder experience meaningful improvements in sleep quality, sleep onset, and nighttime waking following CBT-I. A substantial proportion achieve full remission of insomnia disorder. Research reviewed in Faculty Reviews by Muench, Vargas, Grandner, and colleagues confirms strong, durable outcomes across diverse patient populations. Results vary depending on individual factors, adherence to the program, and the presence of underlying health conditions. A sleep clinician can provide a more personalised assessment.

How long will it take before I feel better with CBT-I?

Many people notice initial improvements in sleep quality within two to four weeks of starting CBT-I, particularly once the homeostatic sleep drive begins to strengthen through sleep restriction therapy. The most significant gains in sleep efficiency and overall sleep quality typically occur by the end of a full course of treatment, which usually spans four to eight weeks. Some people feel more tired in the early weeks before sleep improves, particularly during the sleep restriction phase. Consistent adherence to the sleep schedule, stimulus control guidelines, and relaxation strategies supports faster progress.

Is there anything I can do to make CBT-I easier?

Consistent adherence to the sleep diary, sleep schedule, and stimulus control guidelines makes CBT-I most effective. Setting a fixed wake time every day, including weekends, is one of the most important steps. Keeping alcohol and stimulants low in the hours before bed, managing the sleep environment, and practicing relaxation strategies regularly also support the process. Sleep restriction therapy can feel uncomfortable early on, but maintaining the recommended bedtime window is key to building the homeostatic sleep drive that drives improvement. Discussing any concerns with a health care provider or sleep clinician before and during treatment helps patients stay on track.

Can wearables or nearables help with CBT-I?

Wearable devices such as Oura, Whoop, and Garmin can provide supporting data on sleep patterns, sleep cycles, and sleep duration, which some people find motivating during CBT-I. However, wearable data is not a substitute for a clinical sleep diary or a formal sleep assessment. Overreliance on wearable sleep scores can sometimes increase sleep-related anxiety, which may work against CBT-I goals. Clinicians typically prioritise patient-reported sleep outcomes and sleep diary data over device estimates when making treatment decisions. If you are tracking sleep alongside CBT-I, a clinician can help interpret what wearable data does and does not show.

What is digital CBT-I and is it as effective as in-person treatment?

Digital CBT-I refers to structured CBT-I programs delivered through apps, online platforms, or telehealth. Programs such as Sleepio, Somryst (which has received FDA authorization), and the VA's CBT-I Coach app provide access to core CBT-I components including sleep restriction, stimulus control, cognitive restructuring, and sleep hygiene practices without requiring in-person visits. A Harvard Health commentary by Suzanne Bertisch noted that telehealth-delivered CBT-I shows outcomes comparable to in-person treatment for many patients. Digital CBT programs are particularly useful for people with limited access to behavioral sleep medicine specialists or those with scheduling barriers.

How does CBT-I support relapse prevention?

Relapse prevention is typically addressed in the final sessions of a CBT-I program. Patients learn to identify early warning signs that insomnia symptoms may be returning and to apply CBT-I strategies independently, including returning to a stricter sleep schedule or reapplying stimulus control guidelines during a difficult period. Because CBT-I builds lasting changes in sleep-related behaviors and beliefs rather than suppressing symptoms temporarily, the skills learned during treatment remain available after the program ends. The American Academy of Sleep Medicine emphasises that long-term maintenance of sleep quality is a key advantage of CBT-I over sleep medication.

Where can I find CBT-I treatment or a qualified provider?

CBT-I is available through sleep centers, medical centers, behavioral sleep medicine clinics, and licensed psychologists or therapists with specific CBT-I training. The American Academy of Sleep Medicine maintains a directory of accredited sleep centers and board-certified sleep medicine clinicians. Telehealth options have significantly expanded access, and digital CBT-I programs are available for those who cannot access in-person care. A primary care provider or internal medicine physician can often provide a referral to a sleep clinician. To explore whether biomarker testing or at-home sleep apnea evaluation may also be relevant to your sleep concerns, you can take a free sleep and longevity assessment at Dumbo Health.

Can CBT-I help if I also have restless legs syndrome?

Restless legs syndrome is a neurological condition that can disrupt sleep onset and nighttime sleep quality, and it can coexist with chronic insomnia disorder. CBT-I may help address behavioral and cognitive patterns that have developed around disrupted sleep, but it does not treat restless legs syndrome directly. A healthcare provider should assess and manage the underlying restless legs syndrome separately. Once restless legs symptoms are controlled, CBT-I can be a valuable tool for addressing any remaining insomnia disorder. A sleep clinician experienced in both conditions can help develop an appropriate treatment plan.

Does alcohol affect CBT-I outcomes?

Yes. Alcohol is a common sleep disruptor even though it may initially promote drowsiness. It fragments sleep architecture, suppresses deeper sleep stages, and can worsen nighttime waking in the second half of the night. In CBT-I, sleep hygiene education typically addresses alcohol as one of the foods and substances that interfere with consistent sleep quality. Reducing alcohol in the hours before bed is one of the behavioral changes that supports the stimulus control and sleep restriction components of CBT-I. Patients who drink regularly may find that reducing alcohol independently improves sleep quality alongside formal CBT-I treatment.

Is CBT-I suitable for older adults?

CBT-I is effective and well-studied in older adults and is generally preferred over sleep medication in this population because it avoids the risks associated with sedative pharmacotherapy in older age, including falls, cognitive effects, and dependency. The NIH and the American Academy of Sleep Medicine support CBT-I as the first-line treatment for chronic insomnia across age groups. Sleep restriction therapy may need to be implemented more gradually in older adults, and biological clock considerations, including earlier sleep-wake timing, are commonly addressed. A sleep clinician can tailor the CBT-I program to suit individual needs and health conditions.